NU SKIN ENTERPRISES INC - A (NUS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:NUS - US67018T1051 - Common Stock
9.84 USD
-0.21 (-2.09%)
9.84 USD
0 (0%)
NUS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 36 industry peers in the Personal Care Products industry. Both the profitability and the financial health of NUS get a neutral evaluation. Nothing too spectacular is happening here. NUS is cheap, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year NUS was profitable.
NUS had a positive operating cash flow in the past year.
Of the past 5 years NUS 4 years were profitable.
In the past 5 years NUS always reported a positive cash flow from operatings.
1.2 Ratios
With a decent Return On Assets value of 7.69%, NUS is doing good in the industry, outperforming 75.00% of the companies in the same industry.
The Return On Equity of NUS (13.70%) is better than 80.56% of its industry peers.
NUS has a Return On Invested Capital of 4.08%. This is comparable to the rest of the industry: NUS outperforms 55.56% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NUS is significantly below the industry average of 11.83%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.69% | ||
| ROE | 13.7% | ||
| ROIC | 4.08% |
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
1.3 Margins
With a decent Profit Margin value of 7.02%, NUS is doing good in the industry, outperforming 75.00% of the companies in the same industry.
NUS has a Operating Margin of 3.87%. This is comparable to the rest of the industry: NUS outperforms 50.00% of its industry peers.
In the last couple of years the Operating Margin of NUS has declined.
NUS has a Gross Margin (67.20%) which is in line with its industry peers.
In the last couple of years the Gross Margin of NUS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.87% | ||
| PM (TTM) | 7.02% | ||
| GM | 67.2% |
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NUS is destroying value.
NUS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for NUS has been reduced compared to 5 years ago.
NUS has a better debt/assets ratio than last year.
2.2 Solvency
NUS has an Altman-Z score of 3.76. This indicates that NUS is financially healthy and has little risk of bankruptcy at the moment.
NUS's Altman-Z score of 3.76 is fine compared to the rest of the industry. NUS outperforms 72.22% of its industry peers.
NUS has a debt to FCF ratio of 4.29. This is a neutral value as NUS would need 4.29 years to pay back of all of its debts.
NUS has a better Debt to FCF ratio (4.29) than 83.33% of its industry peers.
A Debt/Equity ratio of 0.26 indicates that NUS is not too dependend on debt financing.
NUS has a Debt to Equity ratio (0.26) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 4.29 | ||
| Altman-Z | 3.76 |
ROIC/WACC0.52
WACC7.92%
2.3 Liquidity
A Current Ratio of 2.15 indicates that NUS has no problem at all paying its short term obligations.
NUS has a Current ratio of 2.15. This is comparable to the rest of the industry: NUS outperforms 52.78% of its industry peers.
NUS has a Quick Ratio of 1.45. This is a normal value and indicates that NUS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.45, NUS is in line with its industry, outperforming 55.56% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.15 | ||
| Quick Ratio | 1.45 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 64.29% over the past year.
Measured over the past years, NUS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -22.85% on average per year.
NUS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.10%.
NUS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.47% yearly.
EPS 1Y (TTM)64.29%
EPS 3Y-41.01%
EPS 5Y-22.85%
EPS Q2Q%100%
Revenue 1Y (TTM)-12.1%
Revenue growth 3Y-13.71%
Revenue growth 5Y-6.47%
Sales Q2Q%-15.33%
3.2 Future
NUS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.90% yearly.
NUS is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.77% yearly.
EPS Next Y54.47%
EPS Next 2Y29.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-13.05%
Revenue Next 2Y-5.77%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 7.13, the valuation of NUS can be described as very cheap.
91.67% of the companies in the same industry are more expensive than NUS, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of NUS to the average of the S&P500 Index (26.92), we can say NUS is valued rather cheaply.
With a Price/Forward Earnings ratio of 6.86, the valuation of NUS can be described as very cheap.
88.89% of the companies in the same industry are more expensive than NUS, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of NUS to the average of the S&P500 Index (23.46), we can say NUS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.13 | ||
| Fwd PE | 6.86 |
4.2 Price Multiples
94.44% of the companies in the same industry are more expensive than NUS, based on the Enterprise Value to EBITDA ratio.
NUS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. NUS is cheaper than 91.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.99 | ||
| EV/EBITDA | 3.91 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NUS's earnings are expected to grow with 29.90% in the coming years.
PEG (NY)0.13
PEG (5Y)N/A
EPS Next 2Y29.9%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.39%, NUS has a reasonable but not impressive dividend return.
NUS's Dividend Yield is a higher than the industry average which is at 2.06.
NUS's Dividend Yield is comparable with the S&P500 average which is at 2.00.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.39% |
5.2 History
The dividend of NUS decreases each year by -30.50%.
NUS has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-30.5%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
10.87% of the earnings are spent on dividend by NUS. This is a low number and sustainable payout ratio.
DP10.87%
EPS Next 2Y29.9%
EPS Next 3YN/A
9.84
-0.21 (-2.09%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners77.08%
Inst Owner Change1.34%
Ins Owners2.12%
Ins Owner Change-1.5%
Market Cap479.70M
Revenue(TTM)1.56B
Net Income(TTM)109.61M
Analysts45
Price TargetN/A
Short Float %5.01%
Short Ratio5.32
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.39% |
Yearly Dividend0.24
Dividend Growth(5Y)-30.5%
DP10.87%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)42.99%
Min EPS beat(2)12.21%
Max EPS beat(2)73.77%
EPS beat(4)4
Avg EPS beat(4)59.11%
Min EPS beat(4)12.21%
Max EPS beat(4)76.64%
EPS beat(8)7
Avg EPS beat(8)43.78%
EPS beat(12)10
Avg EPS beat(12)34.6%
EPS beat(16)13
Avg EPS beat(16)24.83%
Revenue beat(2)1
Avg Revenue beat(2)-1.07%
Min Revenue beat(2)-3.63%
Max Revenue beat(2)1.5%
Revenue beat(4)3
Avg Revenue beat(4)0.39%
Min Revenue beat(4)-3.63%
Max Revenue beat(4)2.51%
Revenue beat(8)5
Avg Revenue beat(8)-0.35%
Revenue beat(12)5
Avg Revenue beat(12)-1.28%
Revenue beat(16)7
Avg Revenue beat(16)-1.32%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.09%
EPS NY rev (1m)3.17%
EPS NY rev (3m)3.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.4%
Revenue NY rev (1m)-1.24%
Revenue NY rev (3m)-1.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.13 | ||
| Fwd PE | 6.86 | ||
| P/S | 0.31 | ||
| P/FCF | 8.99 | ||
| P/OCF | 5.36 | ||
| P/B | 0.6 | ||
| P/tB | 0.71 | ||
| EV/EBITDA | 3.91 |
EPS(TTM)1.38
EY14.02%
EPS(NY)1.43
Fwd EY14.58%
FCF(TTM)1.09
FCFY11.12%
OCF(TTM)1.83
OCFY18.65%
SpS32.01
BVpS16.41
TBVpS13.78
PEG (NY)0.13
PEG (5Y)N/A
Graham Number22.57
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.69% | ||
| ROE | 13.7% | ||
| ROCE | 5.16% | ||
| ROIC | 4.08% | ||
| ROICexc | 5.21% | ||
| ROICexgc | 6.05% | ||
| OM | 3.87% | ||
| PM (TTM) | 7.02% | ||
| GM | 67.2% | ||
| FCFM | 3.42% |
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
ROICexc(3y)6.41%
ROICexc(5y)12.52%
ROICexgc(3y)8.32%
ROICexgc(5y)17.24%
ROCE(3y)6.61%
ROCE(5y)11.76%
ROICexgc growth 3Y-45.58%
ROICexgc growth 5Y-28.67%
ROICexc growth 3Y-42.83%
ROICexc growth 5Y-26.9%
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
F-Score6
Asset Turnover1.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 4.29 | ||
| Debt/EBITDA | 1.8 | ||
| Cap/Depr | 64.7% | ||
| Cap/Sales | 2.31% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 76.96% | ||
| Profit Quality | 48.67% | ||
| Current Ratio | 2.15 | ||
| Quick Ratio | 1.45 | ||
| Altman-Z | 3.76 |
F-Score6
WACC7.92%
ROIC/WACC0.52
Cap/Depr(3y)74.52%
Cap/Depr(5y)79.94%
Cap/Sales(3y)2.68%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.29%
EPS 3Y-41.01%
EPS 5Y-22.85%
EPS Q2Q%100%
EPS Next Y54.47%
EPS Next 2Y29.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.1%
Revenue growth 3Y-13.71%
Revenue growth 5Y-6.47%
Sales Q2Q%-15.33%
Revenue Next Year-13.05%
Revenue Next 2Y-5.77%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-28.1%
EBIT growth 3Y-43.79%
EBIT growth 5Y-28.27%
EBIT Next Year155.65%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y39.66%
FCF growth 3Y-1.31%
FCF growth 5Y-8.9%
OCF growth 1Y-0.72%
OCF growth 3Y-7.59%
OCF growth 5Y-8.88%
NU SKIN ENTERPRISES INC - A / NUS FAQ
Can you provide the ChartMill fundamental rating for NU SKIN ENTERPRISES INC - A?
ChartMill assigns a fundamental rating of 5 / 10 to NUS.
Can you provide the valuation status for NU SKIN ENTERPRISES INC - A?
ChartMill assigns a valuation rating of 9 / 10 to NU SKIN ENTERPRISES INC - A (NUS). This can be considered as Undervalued.
Can you provide the profitability details for NU SKIN ENTERPRISES INC - A?
NU SKIN ENTERPRISES INC - A (NUS) has a profitability rating of 4 / 10.
What is the valuation of NU SKIN ENTERPRISES INC - A based on its PE and PB ratios?
The Price/Earnings (PE) ratio for NU SKIN ENTERPRISES INC - A (NUS) is 7.13 and the Price/Book (PB) ratio is 0.6.
Is the dividend of NU SKIN ENTERPRISES INC - A sustainable?
The dividend rating of NU SKIN ENTERPRISES INC - A (NUS) is 4 / 10 and the dividend payout ratio is 10.87%.